PoD-BIN: A Probability of Decision Bayesian Interval Design for Time-to-Event Dose-Finding Trials with Multiple Toxicity Grades

03/10/2021
by   Meizi Liu, et al.
0

We consider a Bayesian framework based on "probability of decision" for dose-finding trial designs. The proposed PoD-BIN design evaluates the posterior predictive probabilities of up-and-down decisions. In PoD-BIN, multiple grades of toxicity, categorized as the mild toxicity (MT) and dose-limiting toxicity (DLT), are modeled simultaneously, and the primary outcome of interests is time-to-toxicity for both MT and DLT. This allows the possibility of enrolling new patients when previously enrolled patients are still being followed for toxicity, thus potentially shortening trial length. The Bayesian decision rules in PoD-BIN utilize the probability of decisions to balance the need to speed up the trial and the risk of exposing patients to overly toxic doses. We demonstrate via numerical examples the resulting balance of speed and safety of PoD-BIN and compare to existing designs.

READ FULL TEXT

page 1

page 2

page 3

page 4

research
03/28/2023

The Backfill i3+3 Design for Dose-Finding Trials in Oncology

We consider a formal statistical design that allows simultaneous enrollm...
research
04/29/2019

PoD-TPI: Probability-of-Decision Toxicity Probability Interval Design to Accelerate Phase I Trials

Cohort-based enrollment can slow down dose-finding trials since the outc...
research
06/20/2020

A Unified Framework for Time-to-Event Dose-Finding Designs

In dose-finding trials, due to staggered enrollment, it might be desirab...
research
04/24/2023

Generalized Likelihood Ratios for Understanding, Comparing and Constructing Interval Designs of Dose-Finding Studies

Dose-finding studies often include an up-and-down dose transition rule t...
research
12/09/2020

What Were They Thinking? Pharmacologic priors implicit in a choice of 3+3 dose-escalation design

If explicit, formal consideration of clinical pharmacology at all inform...
research
02/14/2020

A Bayesian time-to-event pharmacokinetic model for phase I dose-escalation trials with multiple schedules

Phase I dose-escalation trials must be guided by a safety model in order...
research
09/06/2019

A simulation study of methods for handling disease progression in dose-finding clinical trials

In traditional dose-finding studies, dose-limiting toxicity (DLT) is det...

Please sign up or login with your details

Forgot password? Click here to reset